Robert Michael Floyd

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Hanover, MD
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Michael Floyd

Form 4 holding Chief Operating Officer

Processa Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
89,794
Estimated value
$26,938
Report date
09 Feb 2023
Price
$0.3000
Ownership
by Elion Oncology, Inc.

Insider Reports Filed by Robert Michael Floyd

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .